MedPath

Improving blood glucose control with a lunch-time dose of regular insulin in diabetic patients on twice daily mixed insuli

Not Applicable
Conditions
Nutritional, Metabolic, Endocrine
Diabetes
Registration Number
PACTR201610001812290
Lead Sponsor
Borg El-Arab Hospital, Ministry of Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
All
Target Recruitment
120
Inclusion Criteria

Receiving twice daily insulin only
Have access to a nearby pharmacy or a healthcare unit
Have access to a phone
Baseline HbA1c% of 8 or above

Exclusion Criteria

History of severe hyperglycemia, high risk of hyperglycemia and/or hyperglycemia unawareness
Renal and hepatic patients
Patients with uncontrolled ischemic heart disease
Patients on beta-blockers, glucocorticoids, insulin secretagogues
Pregnant and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.